{"id":1559,"date":"2022-05-19T13:04:03","date_gmt":"2022-05-19T13:04:03","guid":{"rendered":"https:\/\/kthholding.se\/?post_type=dt_portfolio&p=1559"},"modified":"2022-06-21T10:15:34","modified_gmt":"2022-06-21T10:15:34","slug":"neosense-technologies","status":"publish","type":"dt_portfolio","link":"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/","title":{"rendered":"Neosense Technologies"},"content":{"rendered":"

[vc_row el_class=”post-row” css=”.vc_custom_1647333135853{padding-top: 55px !important;}”][vc_column][vc_row_inner el_class=”same-row”][vc_column_inner el_class=”get-back”][vc_column_text el_class=”back-link same-row”]<\/p>\n

\n
<\/div>\n<\/div>\n

Back<\/a>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_single_image image=”1137″ img_size=”medium” el_class=”image-padding”][vc_custom_heading source=”post_title” font_container=”tag:h1|text_align:left” el_class=”post-heading”][vc_row_inner][vc_column_inner width=”2\/3″][vc_column_text el_class=”post-text”]Neosense is developing continuous oxygen monitoring systems for improved control and safety for critically ill patients e.g. newborns.<\/p>\n

Neosense Technologies has developed a world unique sensor for real-time measurement of blood oxygenation. In intensive care it is fundamental to monitor and control blood oxygenation within limits that avoids putting the patient at risk for serious complications. Neosense offer solutions to healthcare providers worldwide with outstanding capability for real time measurement, monitoring, and control of blood oxygenation for critically ill patients.[\/vc_column_text][\/vc_column_inner][vc_column_inner el_class=”center” width=”1\/3″][vc_column_text el_class=”colored-text”]INVESTMENT<\/strong>
\n2014<\/p>\n

WEBB<\/strong>
\nneosen.se<\/a><\/p>\n

STATUS<\/strong>
\nActive<\/p>\n

TAGS<\/strong>
\nMedical device<\/span>, [\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

Continuous oxygen monitoring systems for critically ill patients e.g. newborns.<\/p>\n","protected":false},"author":5,"featured_media":1138,"comment_status":"closed","ping_status":"closed","template":"","dt_portfolio_category":[32],"dt_portfolio_tags":[38],"class_list":["post-1559","dt_portfolio","type-dt_portfolio","status-publish","has-post-thumbnail","hentry","dt_portfolio_category-life-science-en","dt_portfolio_tags-medical-device","dt_portfolio_category-32","description-off"],"acf":[],"yoast_head":"\nNeosense Technologies - KTH Holding AB<\/title>\n<meta name=\"description\" content=\"Neosense is developing continuous oxygen monitoring systems for improved control and safety for critically ill patients e.g. newborns.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neosense Technologies - KTH Holding AB\" \/>\n<meta property=\"og:description\" content=\"Neosense is developing continuous oxygen monitoring systems for improved control and safety for critically ill patients e.g. newborns.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/\" \/>\n<meta property=\"og:site_name\" content=\"KTH Holding AB\" \/>\n<meta property=\"article:modified_time\" content=\"2022-06-21T10:15:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/03\/Neosense-logo-e1655127556583.png\" \/>\n\t<meta property=\"og:image:width\" content=\"276\" \/>\n\t<meta property=\"og:image:height\" content=\"79\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"daniel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kthholding.se\/#website\",\"url\":\"https:\/\/kthholding.se\/\",\"name\":\"KTH Holding AB\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kthholding.se\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#primaryimage\",\"url\":\"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/03\/Neosense-logo-e1655127556583.png\",\"contentUrl\":\"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/03\/Neosense-logo-e1655127556583.png\",\"width\":276,\"height\":79},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#webpage\",\"url\":\"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/\",\"name\":\"Neosense Technologies - KTH Holding AB\",\"isPartOf\":{\"@id\":\"https:\/\/kthholding.se\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#primaryimage\"},\"datePublished\":\"2022-05-19T13:04:03+00:00\",\"dateModified\":\"2022-06-21T10:15:34+00:00\",\"description\":\"Neosense is developing continuous oxygen monitoring systems for improved control and safety for critically ill patients e.g. newborns.\",\"breadcrumb\":{\"@id\":\"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kthholding.se\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portfolio\",\"item\":\"https:\/\/kthholding.se\/project\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Neosense Technologies\"}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neosense Technologies - KTH Holding AB","description":"Neosense is developing continuous oxygen monitoring systems for improved control and safety for critically ill patients e.g. newborns.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/","og_locale":"en_US","og_type":"article","og_title":"Neosense Technologies - KTH Holding AB","og_description":"Neosense is developing continuous oxygen monitoring systems for improved control and safety for critically ill patients e.g. newborns.","og_url":"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/","og_site_name":"KTH Holding AB","article_modified_time":"2022-06-21T10:15:34+00:00","og_image":[{"width":276,"height":79,"url":"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/03\/Neosense-logo-e1655127556583.png","type":"image\/png"}],"author":"daniel","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/kthholding.se\/#website","url":"https:\/\/kthholding.se\/","name":"KTH Holding AB","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kthholding.se\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#primaryimage","url":"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/03\/Neosense-logo-e1655127556583.png","contentUrl":"https:\/\/kthholding.se\/wp-content\/uploads\/2022\/03\/Neosense-logo-e1655127556583.png","width":276,"height":79},{"@type":"WebPage","@id":"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#webpage","url":"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/","name":"Neosense Technologies - KTH Holding AB","isPartOf":{"@id":"https:\/\/kthholding.se\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#primaryimage"},"datePublished":"2022-05-19T13:04:03+00:00","dateModified":"2022-06-21T10:15:34+00:00","description":"Neosense is developing continuous oxygen monitoring systems for improved control and safety for critically ill patients e.g. newborns.","breadcrumb":{"@id":"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kthholding.se\/en\/project\/neosense-technologies\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kthholding.se\/en\/project\/neosense-technologies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kthholding.se\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Portfolio","item":"https:\/\/kthholding.se\/project\/"},{"@type":"ListItem","position":3,"name":"Neosense Technologies"}]}]}},"_links":{"self":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio\/1559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio"}],"about":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/types\/dt_portfolio"}],"author":[{"embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/comments?post=1559"}],"version-history":[{"count":7,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio\/1559\/revisions"}],"predecessor-version":[{"id":2946,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio\/1559\/revisions\/2946"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/media\/1138"}],"wp:attachment":[{"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/media?parent=1559"}],"wp:term":[{"taxonomy":"dt_portfolio_category","embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio_category?post=1559"},{"taxonomy":"dt_portfolio_tags","embeddable":true,"href":"https:\/\/kthholding.se\/en\/wp-json\/wp\/v2\/dt_portfolio_tags?post=1559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}